The Pro Medicus Ltd (ASX: PME) share price has gone up more than 4% after the ASX healthcare share revealed Visage Ease VP for Apple Vision Pro.
Pro Medicus describes itself as a healthcare informatics company which provides a full range of medical imaging software and services to hospitals, imaging centres and healthcare groups.
Visage Ease VP for Apple Vision Pro
Pro Medicus has launched Visage Ease VP, which “supports immersive, spatial experiences for diagnostic imaging and multimedia.”
The company said its cinematic rendering engine provides “stunning volume-rendered images in immersive space.”
On-the-go access with Visage Ease VP has “additional flexibility with virtual screens at more than 4K resolution for each eye.” It uses the input of eyes, hands and voice navigation to provide an end-user imaging experience that’s unlike any other application.
Pro Medicus said UC San Diego Health, a tier 1 academic medical centre and Visage customer, is the first health system to pilot the technology.
The company pointed out that this new spatial imaging offering has the potential to open up a number of “novel and exciting possibilities within both medical imaging and the wider healthcare space.”
Comments
Dr. Paul Murphy, associate clinical professor at UC San Diego School of Medicine and radiologist at UC San Diego Health said:
The visualization of three-dimensional medical imaging in immersive space creates exciting opportunities to improve patient care.
Technology that allows for sophisticated eye motion and gesture controls for reviewing 2D and 3D medical imaging could potentially help in efficient tumor board reviews and create collaborative spaces in healthcare.
Final thoughts on the Pro Medicus share price
The company has a pleasing habit of announcing good news, and this seems to have excited the market again. It’s good to see the company is thinking about the future and able to tap into the latest technology.
At a share price of close to $110, it has an enormous amount of profit growth assumed in the valuation. Is it a good idea that the price/earnings ratio (p/e ratio) keeps rising?
It has looked expensive for a long time, and yet it keeps rising. It’s probably the best business on the ASX, and it’s certainly priced that way.
There are other ASX growth shares I’d rather invest in at the current price.
